Chris M Pillar, PhD

Chris M Pillar, PhD
Chris M Pillar, PhD

Research Assistant Professor, Department of Biomedical Sciences

Contact Information

Email:

Biosketch

Chris Pillar, PhD, is Chief Science Officer with Micromyx, LLC, a microbiology services company specializing in anti-infective discovery and development for the pharmaceutical, biotechnology, and animal health industries.

Dr. Pillar is a graduate of Kalamazoo College in Kalamazoo, Michigan. He earned his doctorate in immunology and microbiology from Wayne State University in Detroit, Michigan. His thesis was based on an investigation into the effects of toxins and proteases of Pseudomonas aeruginosa on the pathogenesis of ulcerative bacterial keratitis. After completing his PhD, Dr. Pillar spent time at both the University of Oklahoma and Harvard Medical School as a postdoctoral fellow. In addition, he worked as a senior scientist at Eurofins Medinet's Global Infectious Diseases Services prior to joining Micromyx.

  • 汤头条app and Training
    • Postdoctoral Fellowship 2007, Ocular Immunology, The Schepens Eye Research Institute, Harvard Medical School
    • Postdoctoral Fellowship 2004, Microbiology and Immunology, Health Sciences Center, The University of Oklahoma
    • PhD 2001, Immunology & Microbiology, Wayne State University
    • BA 1996, Biology, Kalamazoo College

  • Publications

    • Locke J.B., Pillar C.M., Castanheira M., Carvalhaes C.G., Andes D., Aram J.A., Andrzejewski C., Bartizal K., Das A.F., Sandison T., Thompson G.R., Pappas P.G. Antimicrobial Agents and Chemotherapy. 2024;68

    • Jahanbakhsh S., Howland J., Ndayishimiye Uwineza M.O., Thwaites M.T., Pillar C.M., Serio A.W., Anastasiou D.M., Hufnagel D.A. Evaluation of omadacycline against intracellular Mycobacterium abscessus in an infection model in human macrophages JAC-Antimicrobial Resistance. 2023;5

    • Huang D.B., Brothers K.M., Mandell J.B., Taguchi M., Alexander P.G., Parker D.M., Shinabarger D., Pillar C., Morrissey I., Hawser S., Ghahramani P., Dobbins D., Pachuda N., Montelaro R., Steckbeck J.D., Urish K.L. PLoS ONE. 2022;17

    • Kelley C.J., Kennedy-Mendez A., Walser O.N., Thwaites M.T., Arhin F.F., Pillar C.M., Hufnagel D.A. Microbiology Spectrum. 2022;10

    • Cotroneo N., Rubio A., Critchley I.A., Pillar C., Pucci M.J. Antimicrobial Agents and Chemotherapy. 2020;64

    • Kapoor M., Moloney M., Soltow Q.A., Pillar C.M., Shaw K.J. Antimicrobial Agents and Chemotherapy. 2020;64

    • Murray B., Wolfe C., Marra A., Pillar C., Shinabarger D. The Journal of antimicrobial chemotherapy. 2020;75:2149-2155.

    • Pagano P., Marra A., Shinabarger D., Pillar C. The Journal of antimicrobial chemotherapy. 2020;75:2160-2163.

    • Krause K.M., Haglund C.M., Hebner C., Serio A.W., Lee G., Nieto V., Cohen F., Kane T.R., Machajewski T., Hildebrandt D., Pillar C., Thwaites M., Hall D., Miesel L., Hackel M., Burek A., Andrews L.D., Armstrong E., Swem L., Jubb A., Cirz R.T. Antimicrobial Agents and Chemotherapy. 2019;63

    • Pfaller M., Flamm R.K., McCurdy S.P., Pillar C.M., Shortridge D., Jones R.N. Journal of Clinical Microbiology. 2018;56(8)

    • Stapert L., Wolfe C., Shinabarger D., Marra A., Pillar C. Antimicrobial Agents and Chemotherapy. 2018;62(4)

    • Thwaites M., Hall D., Shinabarger D., Serio A., Krause K., Marra A., Pillar C. Antimicrobial Agents and Chemotherapy. 2018;62(8)

    • Thwaites M., Hall D., Stoneburner A., Shinabarger D., Serio A., Krause K., Marra A., Pillar C. Diagnostic Microbiology and Infectious Disease. 2018;92(4):338-345.

    • Wolfe C., Pagano P., Pillar C., Shinabarger D., Boulos R. Diagnostic Microbiology and Infectious Disease. 2018;92(3):250-252.

    • Hall D., Bonifas R., Stapert L., Thwaites M., Shinabarger D., Pillar C. Diagnostic Microbiology and Infectious Disease. 2017;89(3):205-211.

    • Sweeney D., Shinabarger D., Arhin F., Belley A., Moeck G., Pillar C. Diagnostic Microbiology and Infectious Disease. 2017;87(2):121-128.

    • Sweeney D., Shinabarger D., Smart J., Bruss J., Pillar C. Diagnostic Microbiology and Infectious Disease. 2017;89(1):83-85.

    • Sweeney D., Stoneburner A., Shinabarger D.L., Arhin F.F., Belley A., Moeck G., Pillar C.M. Journal of Antimicrobial Chemotherapy. 2017;72(2):622-624.

    • Pillar C.M., Stoneburner A., Shinabarger D.L., Krause K.M., Nichols W.W. Letters in Applied Microbiology. 2016;63(2):96-102.

    • Asbell P.A., Sanfilippo C.M., Pillar C.M., DeCory H.H., Sahm D.F., Morris T. JAMA Ophthalmology. 2015;133(12):1445-1454.

    • Grossman T., Pillar C., Sahm D., Sutcliffe J. Antimicrobial Agents and Chemotherapy. 2015;59(4):2426-2427.

    • Pillar C.M., Stoneburner A., Shinabarger D.L., Abbeloos E., Goby L. Corrigendum to "In vitro susceptibility of bovine mastitis pathogens to a combination of penicillin and framycetin: Development of interpretive criteria for testing by broth microdilution and disk diffusion" (J. Dairy Sci. 97(2015):6594-6607) Journal of Dairy Science. 2015;98(5):3558.

    • Denys G., Pillar C., Sahm D., O'Hanley P., Stephens J. Antimicrobial Agents and Chemotherapy. 2014;58(8):4911-4914.

    • Pillar C.M., Stoneburner A., Shinabarger D.L., Abbeloos E., Goby L. Journal of Dairy Science. 2014;97(10):6594-6607.

    • Morrow B.J., Pillar C.M., Deane J., Sahm D.F., Lynch A.S., Flamm R.K., Peterson J., Davies T.A. Diagnostic Microbiology and Infectious Disease. 2013;75(4):412-416.

    • Sahm D., Deane J., Pillar C., Fernandes P. Antimicrobial Agents and Chemotherapy. 2013;57(9):4535-4536.

    • Tari L.W., Li X., Trzoss M., Bensen D.C., Chen Z., Lam T., Zhang J., Lee S.J., Hough G., Phillipson D., Akers-Rodriguez S., Cunningham M.L., Kwan B.P., Nelson K.J., Castellano A., Locke J.B., Brown-Driver V., Murphy T.M., Ong V., Pillar C.M., Shinabarger D.L., Nix J., Lightstone F.C., Wong S.E., Nguyen T., Shaw K.J., Finn J. PLoS ONE. 2013;8(12)

    • Arhin F., Draghi D., Pillar C., Moeck G., Sahm D. International Journal of Antimicrobial Agents. 2012;40(6):562-563.

    • Pillar C., Goby L. In vitro activity profile of a kanamycin and cefalexin combination against coagulasenegative staphylococci and correlation between MIC and disk zone sizes Udder Health and Communication. 2012:297.

    • Pillar C., Sahm D. Resistance trends and susceptibility profiles in the US among prevalent clinical pathogens: Lessons from surveillance Antibiotic Discovery and Development. 2012;9781461414001:753-792.

    • Prokocimer P., Bien P., DeAnda C., Pillar C.M., Bartizal K. Antimicrobial Agents and Chemotherapy. 2012;56(9):4608-4613.

    • Queenan A.M., Pillar C.M., Deane J., Sahm D.F., Lynch A.S., Flamm R.K., Peterson J., Davies T.A. Diagnostic Microbiology and Infectious Disease. 2012;73(3):267-270.

    • Silley P., Goby L., Pillar C. Journal of Dairy Science. 2012;95(6):3448-3453.

    • Davies T.A., Marie queenan A., Morrow B.J., Shang W., Amsler K., He W., Lynch A.S., Pillar C., Flamm R.K. Journal of Antimicrobial Chemotherapy. 2011;66(10):2298-2307.

    • Haas W., Pillar C.M., Hesje C.K., Sanfilippo C.M., Morris T. Journal of Antimicrobial Chemotherapy. 2011;66(4):840-844.

    • Haas W., Pillar C.M., Torres M., Morris T., Sahm D.F. Monitoring antibiotic resistance in ocular microorganisms: Results from the Antibiotic Resistance Monitoring in Ocular micRorganisms (ARMOR) 2009 surveillance study American Journal of Ophthalmology. 2011;152(4):567-574.e3.

    • Pillar C., Goby L. In vitro activity profile of a kanamycin and cefalexin combination against coagulasenegative staphylococci and correlation between MIC and disk zone sizes Udder Health and Communication. 2011:297.

    • Arhin F., Moeck G., Draghi D., Pillar C., Sahm D. International Journal of Antimicrobial Agents. 2010;36(5):474-476.

    • Haas W., Pillar C.M., Hesje C.K., Sanfilippo C.M., Morris T. Journal of Antimicrobial Chemotherapy. 2010;65(7):1441-1447.

    • Arhin F., Draghi D., Pillar C., Parr T., Moeck G., Sahm D. Antimicrobial Agents and Chemotherapy. 2009;53(11):4762-4771.

    • Haas W., Pillar C.M., Zurenko G.E., Lee J.C., Brunner L.S., Morris T. Antimicrobial Agents and Chemotherapy. 2009;53(8):3552-3560.

    • Pillar C., Goby L., Draghi D., Grover P., Thornsberry C. Journal of Dairy Science. 2009;92(12):6217-6227.

    • Draghi D., Benton B., Krause K., Thornsberry C., Pillar C., Sahm D. Journal of Antimicrobial Chemotherapy. 2008;62(1):116-121.

    • Draghi D.C., Benton B.M., Krause K., Thornsberry C., Pillar C., Sahm D.F. Antimicrobial Agents and Chemotherapy. 2008;52(7):2383-2388.

    • Pillar C., Draghi D., Sheehan D., Sahm D. Diagnostic Microbiology and Infectious Disease. 2008;60(2):221-224.

    • Pillar C., Torres M., Brown N., Shah D., Sahm D. Antimicrobial Agents and Chemotherapy. 2008;52(12):4388-4399.

    • Pillar C.M., Aranza M.K., Shah D., Sahm D.F. Journal of Antimicrobial Chemotherapy. 2008;61(3):595-602.

    • Pillar C.M., Draghi D.C., Dowzicky M.J., Sahm D.F. Journal of Clinical Microbiology. 2008;46(9):2862-2867.

    • Shaw K.J., Poppe S., Schaadt R., Brown-Driver V., Finn J., Pillar C.M., Shinabarger D., Zurenko G. Antimicrobial Agents and Chemotherapy. 2008;52(12):4442-4447.

    • Coburn P.S., Pillar C., Jett B.D., Haas W., Gilmore M.S. Science. 2004;306(5705):2270-2272.

    • Pillar C., Gilmore M.S. Frontiers in bioscience : a journal and virtual library. 2004;9:2335-2346.

    • Rumpel S., Razeto A., Pillar C., Vijayan V., Taylor A., Giller K., Gilmore M.S., Becker S., Zweckstetter M. EMBO Journal. 2004;23(18):3632-3642.

    • Pillar C.M., Hobden J.A. Investigative Ophthalmology and Visual Science. 2002;43:1437-1444.

    • Pillar C.M., Hazlett L.D., Hobden J.A. Current Eye Research. 2000;21:730-739.